Fast-track CJD trial: two years late, but not derailed.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000639:trends*; D007562:Creutzfeldt-Jakob Syndrome / Q000188:drug therapy*; D006801:Humans; D011796:Quinacrine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011796:Quinacrine